Press Releases June 8, 2026 04:01 PM

Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer

Mannatech Names Yasir Haider as Permanent Chief Financial Officer to Drive Financial Discipline and Growth

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
MTEX

Mannatech, Incorporated has appointed Yasir Haider as its new Chief Financial Officer, effective June 3, 2026. Haider, who has served as Interim CFO since March 2026 and joined Mannatech in January 2025 as Controller, brings extensive experience in global finance operations, SEC reporting, and M&A. The company aims to leverage his expertise to enhance financial management and accelerate operational performance, strengthening long-term shareholder value.

Mannatech Announces Appointment of Yasir Haider as Chief Financial Officer
MTEX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Yasir Haider promoted from Interim CFO to permanent CFO, highlighting confidence in his leadership.
  • Haider's background includes global financial operations, SEC reporting, mergers and acquisitions, and scalable finance infrastructure development.
  • Mannatech is focused on improving financial discipline, operational performance, and long-term value creation for shareholders.

FLOWER MOUND, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX) announces that on June 3, 2026, Yasir Haider was appointed Chief Financial Officer of Mannatech, Incorporated (the "Company").

Mr. Haider joined the Company on January 6, 2025, as the Company’s Controller. Prior to joining the Company, Mr. Haider held senior finance leadership roles, including Chief Financial Officer and Financial Controller, where he was responsible for global financial operations, multi-entity consolidations, financial reporting, and capital planning across complex organizations. His experience includes SEC reporting, mergers and acquisitions, and the development of scalable financial infrastructure to support operational growth. Mr. Haider began his career in public accounting and holds an MBA from West Texas A&M University.

As previously announced, Mr. Haider was appointed Interim Chief Financial Officer on March 20, 2026, by the Company’s board of directors to facilitate the transition of duties from the Company’s former Chief Financial Officer, James Clavijo.

Commenting on Mr. Haider’s promotion, Landen Fredrick, the Company’s President and CEO, stated, “Yasir has earned this opportunity through the way he has stepped into the role, brought discipline to our financial processes, and helped us manage the business with greater focus and accountability. He understands where Mannatech is today, where we need to go, and the importance of executing with urgency and precision. I am confident Yasir will be a strong financial leader for the Company as we continue working to improve performance and create long-term value for our shareholders.”

About Mannatech:
Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life through cutting-edge, science-backed nutritional products, patented technology, and a rewarding business opportunity. With operations in 25 markets†, Mannatech helps people to live healthier, more fulfilling lives while making a positive social impact in the world. Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Mannatech.com.

†Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.

 

Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

 

Contact Information:
Erin Barta
General Counsel and Corporate Secretary
[email protected]
www.mannatech.com


Risks

  • Potential challenges in attracting and retaining associates and members impacting sales growth.
  • Competitive pressures and regulatory changes in global health and wellness markets.
  • Uncertainties related to international expansion and cross-border e-commerce operations, such as in China.

More from Press Releases

Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation Jun 8, 2026 Snow Rothschild Acquisition Corp. Announces Pricing of $200 Million Initial Public Offering Jun 8, 2026 Cal-Maine Foods to Participate in D.A. Davidson Technology & Consumer Conference Jun 8, 2026 Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026 Jun 8, 2026 DBV Technologies to Present New Positive Data from VITESSE Study and Preview Recently Initiated THRIVE Study at the EAACI Congress 2026 Jun 8, 2026